Fischer Imaging – Improving outcomes for cancer patients with advanced imaging technology
Until there is a cure, early detection is our best weapon against breast cancer. Fischer Imaging is focused on fixing the failings of Mammography, the standard of care of early breast cancer detection.
Our advanced technology will find more early cancers, reduce false positives, reduce radiation dose and make mammography more acceptable to women.
Company Overview
Fischer Imaging is a development-stage company focused on better mammography for detecting early breast cancer. This is a massive $2B+ replacement market that has experienced only incremental improvements for decades.
- The Clinical Gap: Breast cancer is highly curable when caught early, yet traditional mammography still misses crucial cancers, creates costly false alarms, and performs poorly on women with dense breast tissue (nearly 50% of the female population).
- The Patient Barrier: Traditional screenings require painful breast compression. Because of this pain, over a third of all women avoid getting mammograms altogether—often leading to delayed diagnoses and poorer outcomes.
Our Partners
